ARCHIVES

NCI Dispute GAO Charge That Cancer Control Contracts Were Mishandled

This article is from The Cancer Letter archive.

Vol. 06 No. 33 | August 15, 1980

Download PDF Visit The Full Archive

Related Articles

NCI Sets its Targets for Grant Success Rate and R01 Payline for FY05.

January 21, 2005

In Brief: Hellman to Leave Memorial This Fall For Position As Dean, Vice President at Univ. Of Chicago

April 8, 1988

NCI advisors approve recompetition of $62 million phase II contracts program.

November 19, 2004

Taxol Approved By FDA For Ovarian Cancer; Bristol Sets Price Tier In Line With Platinum

January 8, 1993

Joint NCI/FDA Program approved; ‘May Solve Our Differences’

December 15, 1989

ACOS Survey To Assess Tumor Boards’ Impact On Patient Care

January 24, 1986